Octagon Capital Advisors as of Sept. 30, 2021
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 30 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| I Mab Sponsored Ads (IMAB) | 13.6 | $55M | 765k | 72.49 | |
| Apellis Pharmaceuticals (APLS) | 13.0 | $53M | 1.6M | 32.96 | |
| Celldex Therapeutics Com New (CLDX) | 10.1 | $41M | 761k | 53.99 | |
| Arcus Biosciences Incorporated (RCUS) | 8.3 | $34M | 970k | 34.87 | |
| Bridgebio Pharma (BBIO) | 6.6 | $27M | 569k | 46.87 | |
| 4d Molecular Therapeutics In (FDMT) | 5.5 | $22M | 831k | 26.97 | |
| Gossamer Bio (GOSS) | 4.7 | $19M | 1.5M | 12.57 | |
| Curis Com New | 4.4 | $18M | 2.3M | 7.83 | |
| Century Therapeutics (IPSC) | 3.7 | $15M | 603k | 25.16 | |
| Arvinas Ord (ARVN) | 3.4 | $14M | 169k | 82.18 | |
| Vera Therapeutics Cl A (VERA) | 3.0 | $12M | 696k | 17.35 | |
| Avidity Biosciences Ord (RNA) | 2.7 | $11M | 447k | 24.63 | |
| Cytek Biosciences (CTKB) | 2.6 | $11M | 500k | 21.41 | |
| Dyne Therapeutics (DYN) | 2.3 | $9.5M | 584k | 16.24 | |
| Connect Biopharma Hldgs Ads (CNTB) | 1.9 | $7.8M | 326k | 23.90 | |
| Stoke Therapeutics (STOK) | 1.9 | $7.6M | 297k | 25.44 | |
| Omega Therapeutics Common Stock (OMGA) | 1.7 | $7.0M | 370k | 18.85 | |
| Cardiff Oncology (CRDF) | 1.6 | $6.5M | 983k | 6.66 | |
| Prometheus Biosciences | 1.2 | $4.7M | 200k | 23.71 | |
| Ambrx Biopharma Sponsored Ads | 1.2 | $4.7M | 350k | 13.50 | |
| Iveric Bio | 1.1 | $4.5M | 277k | 16.24 | |
| Ngm Biopharmaceuticals (NGM) | 1.0 | $4.2M | 200k | 21.02 | |
| Helix Acquisition Corp Com Cl A | 1.0 | $3.9M | 400k | 9.87 | |
| Ikena Oncology (IKNA) | 0.9 | $3.5M | 275k | 12.62 | |
| Monte Rosa Therapeutics (GLUE) | 0.8 | $3.3M | 150k | 22.28 | |
| Pmv Pharmaceuticals (PMVP) | 0.7 | $3.0M | 100k | 29.80 | |
| Jiya Acquisition Corp Com Cl A | 0.7 | $2.9M | 300k | 9.78 | |
| Edgewise Therapeutics (EWTX) | 0.2 | $830k | 50k | 16.60 | |
| Design Therapeutics (DSGN) | 0.1 | $219k | 15k | 14.67 | |
| Tenax Therapeutics Com New | 0.0 | $54k | 31k | 1.76 |
